BnH Research is a biotechnology and health care startup established in 2015. Recently, the company received a significant KRW12.00B Series B investment on 18 March 2022. This round of funding was supported by a consortium of investors including UTC 2019 BioVentureFund, LSK Investment, WE Ventures, Honest Ventures, PNP Investment, and CKD Venture Capital Corporation.
As a biotech and health care-focused company, BnH Research operates in industries that are of growing importance and investment interest. The recent funding injection puts the company in a strong position to further develop and commercialize its innovative solutions in these sectors.
